| Ytd | -38.46% | |
| 1y | -61.64% |
| Open | 1.32 | Prev Close | 1.20 | Low | 1.06 | High | 1.32 | Mkt Cap | 4.26M |
| Vol | 2.27M | Avg Vol | 146.40K | EPS | -3.67 | P/E | N/A | Forward P/E | -0.26 |
| Beta | -0.04 | Short Ratio | 1.03 | Inst. Own | 0.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-02 | 50-d Avg | 1.14 | 200-d Avg | 1.83 | 1yr Est | 32.00 |
Gainers Can Fite Biopharma (AMEX:CANF) stock moved upwards by 52.0% to $4.52 during Wednesday's
Gainers Alzamend Neuro (NASDAQ:ALZN) stock increased by 12.9% to $1.35 during Tuesday's after-m